Betok Fish (Anabas testudineus) Oil Decreases Inflammatory Cytokine through Increasing Vitamin D Level in Rats-induced Systemic Lupus Erythematosus by Salim, Eddy Mart et al.
234 https://www.id-press.eu/mjms/index
Scientific Foundation SPIROSKI, Skopje, Republic of Macedonia
Open Access Macedonian Journal of Medical Sciences. 2020 May 21; 8(A):234-238.
https://doi.org/10.3889/oamjms.2020.3839
eISSN: 1857-9655
Category: A - Basic Sciences
Section: Immunology
Betok Fish (Anabas testudineus) Oil Decreases Inflammatory 
Cytokine through Increasing Vitamin D Level in Rats-induced 
Systemic Lupus Erythematosus
Eddy Mart Salim1, Radiyati Umi Partan1, Rachmat Hidayat2*
1Department of Internal Medicine, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia; 2Department of Biology, 
Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia
Introduction
Systemic lupus erythematosus (SLE) is an 
autoimmune disorder characterized by the production of 
antibodies to the cell’s core components. Pathological 
conditions found in SLE patients are associated 
with inflammatory processes, vasculitis, deposition 
of immune complexes, and vasculopathy [1]. The 
inflammatory process is a major pathological condition 
in SLE disorders. SLE begins with the formation of 
antibodies against the individual cell components 
themselves, and anti-double stranded DNA (dsDNA) is 
found in 95% of cases. The prevalence of SLE in the 
Asia Pacific region is 4.3–45.3 per 100,000 population. 
Meanwhile, the prevalence of SLE in Indonesia is 
0.5%, and the prevalence is increasing from year to 
year. There are 16,000 new cases of SLE in the United 
States each year. This showed that the number of 
new cases of SLE is very significant and continues to 
grow every year. Therefore, optimal comprehensive 
efforts are needed to explore pathophysiology and a 
comprehensive therapeutic approach [2].
The increase in ds-DNA in SLE is 
triggered by an increase in B cell population due to 
decreased T cell production, which is initiated by 
interleukin-2 (IL-2) production [3]. Increased IL-2 will 
encourage the activation of Th-17 cells to produce 
IL-17. Furthermore, this condition will activate the 
inflammatory cascade, which is mediated by IL-1, IL-6, 
and tumor necrosis factor-alpha (TNF-α), which is 
responsible for damage in various target organs and will 
eventually cause damage and target organ failure [4], [5]. 
Compounds 2, 6, 10, 14-tetramethylpentadecane or 
commonly known as pristane are compounds used 
for the induction of SLE in Wistar rats (Strain of mice: 
Mus musculus). This compound will induce chronic 
inflammation so that it initiates an increase in ds-DNA 
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autoantibodies which will trigger an inflammatory 
cascade and target organ damage in SLE [6], [7], [8].
Vitamin D is a steroid hormone that plays a role in 
the regulation of cell growth, proliferation, apoptosis, and 
regulation of the immune system. Vitamin D deficiency is 
a clinical condition that worsens clinical SLE. Decreased 
levels of Vitamin D are common in SLE patients. Giving 
immunosuppressant drugs (glucocorticoids) will trigger 
a decrease in vitamin D levels. However, this drug is 
a standard drug consumed by SLE patients. Vitamin D 
has the capacity to suppress the immune response so 
it will suppress the inflammatory cascade. Vitamin D 
supplementation in SLE patients becomes strategic 
management, because it can reduce clinical problems 
optimally in SLE patients [8], [7], [9].
Exploration of Vitamin D sources is one of 
the important ways to improve the management of 
SLE disorders. Betok fish (Anabas testudineus) are a 
freshwater fish that are commonly found in the Musi 
River, South Sumatra, Indonesia. Like seluang fish 
(Rasbora spp.) which is a freshwater fish that are often 
found in the Musi River, Betok fish have similarities with 
seluang fish, both of which are first-rate consumers 
and both have similarities in terms of the amount of 
oil content found in scales and the bodies of the fish. 
Seluang fish oil has been shown to contain Vitamin 
D which is quite high, 2043.34 IU/mL [10]. As well as 
seluang fish oil, betok fish oil is rich in vitamin D content. 
High Vitamin D content is believed to be able to play 
a role in the regulation of the immune response and 
able to suppress the inflammatory cascade in SLE. Of 
course, this research was a significant and first attempt 
at utilizing betok fish oil to explore natural sources of 
Vitamin D that could reduce inflammation in SLE.
Methods
Animal
A total of 30 male Wistar rats (200 ± 20 g) 
were obtained from Eureka Research Laboratory 
(Palembang, Indonesia). Experimental animals were 
placed in cages under controlled conditions (12 h of 
light/dark cycles with temperatures of 22 ± 1°C and 
humidity of 40–60%), fed and drank ad libitum. All 
animal treatments and experimental procedures were 
approved by the Ethics and Humanities Commission of 
the Faculty of Medicine, Universitas Sriwijaya (No.176/
kptfkunsri-rsmh/2019).
Fish oil processing and analysis of Vitamin D
About 30 kg of betok fish were obtained from 
the Palembang Fish Auction Center, South Sumatra, 
Indonesia, in May 2019. Fish were then kept in a 
refrigerator −25°C to minimize biochemical changes 
during fish transportation from the Auction Center to 
the Biotechnology Laboratory, Faculty of Medicine, 
Universitas Sriwijaya (Palembang, Indonesia). Next, 
the whole body of betok fish were grinded and stored 
under −25°C until used.
Grinded betok fish were previously thawed 
at room temperature for 8 h, then as much as 1 L of 
water was added to every 200 g of flesh of the betok 
fish, then heating at 95°C for 30 min. Then, grinded fish 
were pressured, then, coextracted water together with 
oil. The third stage was centrifuging with a speed of 
5000 rpm, temperature of 25°C, for 10 min. Furthermore, 
oil was separated from colloids and water. Around 
15 μL of sample was injected to high-performance 
liquid chromatography (Shimadzu), spherical column 
C 18, mobile phase methanol: Aquadest (90:10), flow 
rate 0.8 ml/min, ultraviolet detector λ = 254 nm. The 
examination was carried out for analysis of Vitamin D 
content in betok fish oil [11], [12], [13], [14], [15].
Induction and treatment of experimental 
animals
Thirty male Wistar rats were randomly divided 
into the six groups: (1) Betok fish oil Group 1 0.1 mL/kg 
BW group: Five rats received a single intraperitoneal 
(ip) injection 0.5 ml pristane (Sigma-Aldrich, USA) on 
day 1 and given betok fish oil every day starting on 
day 2 for 3 months; (2) Betok fish oil Group 2 (BFO2) 
0.2 mL/kg BW group: Five rats received 0.5 ml ip 
injection of pristane on day 1 and were given fish oil 
0.2 mL/kg BW every day starting on day 2 for 3 months; 
(3) Betok fish oil Group 3 0.4 mL/kg BW group: Five 
rats received 0.5 ml ip injection of pristane on day 1 
and were given fish oil 0.4 mL/kg BW every day starting 
on day 2 for 3 months; (4) normal control group: Five 
rats were not injected with pristane and were not given 
fish oil; (5) negative control group: Five rats received 
i.p 0.5 ml pristane injection on day 1 and were given 
Aquadest 0.4 mL/kg BW every day starting on day 2 
for 3 months; and (6) positive control group: Five rats 
received i.p 0.5 ml pristane injection on day 1 and were 
given 100 IU/kg BW every day starting on day 2 for 
3 months.
Enzyme-linked immunosorbent assay 
(ELISA)
The ELISA method was used to assess 
ds-DNA levels and Vitamin D levels. Examination of 
ds-DNA levels and Vitamin D levels was performed first 
by taking blood from rats. Rats were first anesthetized 
with Ketamine 50 mg/kg BW and Xylazine 5 mg/kg BW. 
Blood was put into a non-EDTA tube, then centrifugation 
was carried out at a speed of 5000 rpm for 10 min, 
a temperature of 25°C. The supernatant from the 
centrifugation results was then taken and put into a 
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1.5 mL centrifuge tube to be stored at −20°C until used 
for ELISA examination.
The levels of ds-DNA and Vitamin D in serum 
were carried out using the Rat ELISA kit ds-DNA and 
Vitamin D (Cloud Clone), based on the protocol found 
in the manufacturer’s protocols. Briefly, 50 μl standard 
diluents or serum samples were added to wells that 
had been coated with anti-ds-DNA; the anti-Vitamin D 
was incubated at 37°C for 30 min. After the plates were 
washed, 100 µl of biotinylated antibody solution was 
added and incubated for 30 min at 37°C. After washing 
3 times, 50 ul avidin-peroxidase complex solution was 
added and incubated for 15 min at 37°C. After washing, 
50 μl of the tetramethylbenzidine color solution was 
added and incubated in the dark for 15 min at 37°C. 
Finally, 50 ul stop solutions were added to stop the 
reaction and optical density values were measured 
using an ELISA reader (Bio-Rad), wavelength 450 nm.
Western blot assay
This method was used to confirm the ELISA 
examination of pro-inflammatory cytokine (TNF-α). This 
process began with the stage of protein extraction. The 
sample supernatant was put into a RIPA buffer (Sigma-
Aldrich) equipped with phenylmethanesulfonyl fluoride 
on ice for 5 min. After centrifugation at 12,000 rpm for 
10 min at 4°C, the supernatant was collected as total 
protein lysate. Cytoplasmic protein and nucleus were 
extracted from synovial tissue using a protein extraction 
kit (Sigma-Aldrich), based on manufacturer’s protocol. 
Concisely, synovial tissue was cut into small pieces 
and homogenized with a protein extraction agent. After 
incubation on ice for 15 min and centrifugation at 5000 rpm 
for 5 min at 4°C, the supernatant was collected as a partial 
cytoplasmic protein, while the pellet was re-extracted 
again in the extraction buffer. After incubation on ice 
for 15 min and centrifugation at 12,000 rpm for 5 min at 
4°C, the supernatant was combined with the cytoplasmic 
protein above. The pellet was then extracted again in an 
extraction buffer and shaken violently for 30 min at 4°C. 
After centrifugation at 12,000 rpm for 10 min at 4°C, protein 
was obtained. Total protein concentration was quantified 
using the bicinchoninic acid assay protein assay (Sigma-
Aldrich) kit, according to the manufacturer’s protocol.
A total of 40 ug of protein extract was 
separated at sodium dodecyl sulfate polyacrylamide 
gel electrophoresis 10%. Furthermore, the protein 
that has been separated was transferred to the PVDF 
membrane (Millipore) and blocked with 5% nonfat milk 
in Tris-buffered saline with Tween 20 for 1 h at room 
temperature. The membrane was incubated overnight 
at 4°C with the rabbit polyclonal TNF-α 1:700 primary 
antibodies (Cloud Clone). Next, the membrane was 
incubated with horseradish peroxidase-conjugated 
antibodies at 1:5000 for 45 min within temperature 
of 37°C. Next, visualization of the results of blotting 
with chemiluminescence (Bio-Rad) was performed. 
Standardization of blotting results was done by blotting 
on β-actin.
Statistical analysis
All data were presented as mean±standard 
deviation and all statistical analyses are performed 
with the SPSS 25 (IBM) program. One-way ANOVA 
followed by post hoc analysis was carried out to assess 
differences in the mean expression levels of each 
protein. p < 0.05 was determined as an indication that 
there were significant differences in the mean levels.
Results
Betok fish oil is fish oil derived from freshwater 
fish, where this fish are classified as the first level 
consumer. Table 1 shows that the Vitamin D content in 
betok fish oil is quite high at 2021.43 IU/mL. Vitamin D 
Table 1: Vitamin D level in betok fish oil
Active compound Quantity
Vitamin D 2021,43 IU/mL
levels contained in the fish oil are quite high compared 
to Vitamin D supplements that are sold on the market.
Pristane induction showed the potential for 
inducing autoimmune conditions through increased 
ds-DNA autoantibodies, as seen in negative controls. 
Table 2 shows the efficacy of betok fish oil in reducing 
the level of ds-DNA autoantibodies with increasing 
doses of fish oil.
Table 2: Level of ds-DNA in serum
S. No. Group ds-DNA (pg/mL)±SD p value*
1. Control normal 34.26 ± 2.54 0.00
2. Control positive 176.36 ± 11.12 0.00
3. Control negative 676.76 ± 9.54 -
4. Betok fish oil Group 1 476.34 ± 23.76 0.00
5. Betok fish oil Group 2 328.11 ± 17.43 0.00
6. Betok fish oil Group 3 154.77 ± 11.87 0.00
*Versus negative control, ANOVA, post hoc Bonferroni; p<0.05.
Figure 1 shows that giving fish oil at a dose of 
0.4 mL/kg BW is more effective than positive control 
Figure  1:  Effects  of  betok  fish  oil  in  Vitamin  D  in  systemic  lupus 
erythematosus rats. *p < 0.05 versus negative group; ANOVA, post 
hoc Bonferroni
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in increasing serum Vitamin D levels. These results 
indicate the effectiveness of betok fish oil in increasing 
serum Vitamin D levels in SLE-induced rats.
Figure 2 shows that the supplementation of 
betok fish oil was able to reduce the expression of 
pristane is believed to be able to be a model of SLE 
induction in experimental animals [18], [19], [20].
Damage caused by antigen binding (ds-DNA 
and ANA) with antibodies will cause activation and 
recruitment of various immune responses by releasing 
various pro-inflammatory mediators, such as TNFα 
and IL-1β. Subsequent pro-inflammatory mediators 
will cause more massive damage due to immunogenic 
inhibitory activity [21], [22], [20]. Vitamin D is a regulator 
that plays a role in maintaining the body’s defense 
system homeostasis. Vitamin D acts as a regulator of 
various gene expressions that play a role in the activation 
and inhibition of immune cells. In an autoimmune 
condition where immune system reactivation occurs, 
Vitamin D will act as a regulator of the expression of 
anti-inflammatory cytokine genes, which will provide 
negative feedback from immune cell activation, which 
in turn leads to inhibition of immune cells. Betok fish oil, 
which is rich in Vitamin D, is a potential for exploration 
and development of new therapeutic modalities for SLE 
treatment [23], [24], [25].
This study showed that the provision of fish 
oil can reduce the expression of pro-inflammatory 
cytokines, TNF-α, along with the ability of fish oil to 
reduce the expression of autoantibodies, ds-DNA, and 
fish oil also can increase vitamin D levels in serum 
induced white rats with pristane.
Conclusion
Betok fish oil has efficacy in reducing levels of 
ds-DNA autoantibodies in SLE rats by decreasing the 
inflammatory response through upregulation of Vitamin 
D in serum.
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